Tissue, Cell-Based Product Reg Needs Some Clarification - FDA Staffers
This article was originally published in The Gray Sheet
Executive Summary
FDA's proposed rule to establish regulations on human cellular or tissue-based medical equipment requires further clarification, agency staffers acknowledged.
You may also be interested in...
Rhakoss Spinal Implant May Be Safer Alternative To Allograft – Orthovita
Orthovita is emphasizing its Rhakoss synthetic bone spinal implant as a potentially safer alternative to allograft for cervical spinal fusion surgery
Rhakoss Spinal Implant May Be Safer Alternative To Allograft – Orthovita
Orthovita is emphasizing its Rhakoss synthetic bone spinal implant as a potentially safer alternative to allograft for cervical spinal fusion surgery
Tissue Regs On Horizon Despite Manufacturer Concerns
FDA should regulate threaded cortical bone dowels as a device, rather than a tissue, because it is indicated for a specific use, Stryker Biotech maintains in comments to the agency.